insights_auto
Why is ARX up 2,54%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,50 A$
arrow_upward
+2,54%(+0,012) 1D
18 նոյ, 16:00:00 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 A$
High
0,51 A$
Low
0,49 A$
Mkt. cap
168,69 մլն
Avg. vol.
260,07 հզր
Volume
237,73 հզր
P/E ratio
48,10
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
Open
0,50 A$
High
0,51 A$
Low
0,49 A$
Mkt. cap
168,69 մլն
Avg. vol.
260,07 հզր
Volume
237,73 հզր
P/E ratio
48,10
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
47 րոպե առաջ
S&P 500 Premarket Movers on Nov. 18
TradingView
·
32 րոպե առաջ
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
The Motley Fool
·
28 րոպե առաջ
Investors Love the S&P 500 Index. Here’s Why I Don’t.
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd